Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenomic Biomarkers for Improved Drug Therapy-Recent Progress and Future Developments.

The AAPS journal - 27 Nov 2017

Lauschke Volker M, Milani Lili, Ingelman-Sundberg Magnus

Abstract excerpt

Much of the inter-individual variability in drug efficacy and risk of adverse reactions is due to polymorphisms in genes encoding proteins involved in drug pharmacokinetics and pharmacodynamics or immunological responses. Pharmacogenetic research has identified a multitude of gene-drug response associations, which have resulted in genetically guided treatment and dosing decisions to yield a higher success rate of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers
Share to Genetic Variation
Share to Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Oncogenes

Share to Patient Satisfaction

Share to Pharmacogenetics

Share to Polymorphism, Genetic

Share to Precision Medicine

Source

Identifiers

PMID: 29181807
DOI: 10.1208/s12248-017-0161-x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenomic Biomarkers for Improved Drug Therapy-Recent Progress and Future Developments.PMID 29181807Read ↗

Personalized Pharmacogenomics: Predicting Efficacy and Adverse Drug ReactionsSemantic proximity Read ↗

Pharmacogenomics: historical perspective and current status.Semantic proximity Read ↗

Impact of pharmacogenomics on the clinical laboratory.Semantic proximity Read ↗

Pharmacogenomics: An evolving clinical tool for precision medicine.Semantic proximity Read ↗

Pharmacogenomic Profiling of ADME Gene Variants: Current Challenges and Validation PerspectivesSemantic proximity Read ↗

Progress towards the integration of pharmacogenomics in practice.Semantic proximity Read ↗

The emerging era of pharmacogenomics: current successes, future potential, and challenges.Semantic proximity Read ↗

Pharmacogenetics and pharmacogenomics of anticancer agents.Semantic proximity Read ↗

Pharmacogenomics guidelines: Current status and future developmentSemantic proximity Read ↗

Pharmacogenomics: role in medicines approval and clinical use.Semantic proximity Read ↗

Impact of Pharmacogenomics in Clinical PracticeSemantic proximity Read ↗

Pharmacogenomic biomarkers.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.